Imaging Technologies and Diagnostic tests of Biomarkers


In clinical trials using imaging, biomarkers and response criteria are used to assess the tumor evolution with therapy. Imaging biomarkers are often root contributors to a clinical trial’s endpoints, but they are not the same. Diagnostic tests and the biological biomarker (biomarkers) they measure are often classified based on the circumstances under which they are used. Biomarkers provide information about a patient at virtually every stage of care. They can help doctors evaluate the likelihood that a patient will develop a disease, diagnose a disorder, evaluate the severity of a disorder and/or its likely progression, determine optimal treatment strategies and monitor response to treatment.


    Related Conference of Imaging Technologies and Diagnostic tests of Biomarkers

    April 10-11, 2025

    31st Asia Pacific Biotechnology Congress

    Singapore City, Singapore
    June 16-17, 2025

    28th World Congress on Biotechnology

    Amsterdam, Netherlands
    June 23-24, 2025

    28th European Biotechnology Congress

    Paris, France
    September 15-16, 2025

    29th Global Congress on Biotechnology

    Aix-en-Provence, France
    December 04-05, 2025

    9th International Conference on Protein Engineering

    Paris, France

    Imaging Technologies and Diagnostic tests of Biomarkers Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in